Understanding how trauma affects blood stem cells in elderly patients
Official title: Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury: Chronic Stress and Anemia Recovery Following Major Trauma
Run by University of Florida · NCT02577731 · Data updated 2026-11-12
This study looks at how severe trauma affects blood stem cells in older patients to see if it changes their recovery and risk of infections compared to those who haven't been injured.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | University of Florida Academic / other |
| Drugs / interventions | Chemotherapy, Radiation |
| Locations | 1 site (Gainesville, Florida) |
| Status | Recruiting |
| Started | January 2014 |
| Main results expected | December 28, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | January 15, 2026 |
| Trial ID | NCT02577731 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who have experienced severe blunt or penetrating trauma resulting in significant injuries.
✕Probably not a fit
Patients with minor injuries or those not meeting the trauma criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the changes in hematopoietic stem cells (HSCs) in elderly patients following severe trauma compared to non-injured individuals. It involves collecting bone marrow and blood samples from three groups: patients undergoing elective hip surgery, trauma patients, and healthy controls. The samples will be analyzed for various parameters, including genomic expression and inflammatory markers, to understand the emergency myelopoiesis response and its implications for recovery and infection susceptibility. Clinical data will also be collected to monitor patient outcomes during hospitalization.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment strategies for elderly patients suffering from severe trauma.
How similar studies have gone: While there have been studies on trauma and stem cell responses, this specific focus on elderly patients and the detailed analysis of HSCs post-trauma is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Severe Trauma Population Inclusion criteria will be: 1. All adults (age ≥18 to 54) 2. Blunt and/or penetrating trauma resulting in long bone or pelvic fractures requiring ORIF or closed reduction percutaneous pinning (CRPP). 3. Blunt and/or penetrating trauma patient with either: 1. hemorrhagic shock defined by: i. systolic BP (SBP) ≤ 90 mmHg or ii. mean arterial pressure≤ 65 mmHg or iii. base deficit (BD) ≥ 5 meq or iv. lactate ≥ 2 2. Or injury severity score (ISS) greater than or equal to 15. 4. All adults (age 55 and older) require: 1. Blunt and/or penetrating trauma resulting in log bone or pelvic fractures requiring ORIF or CRPP 2. Either hemorrhagic shock defined by: i. Systolic BP (SBP) ≤ 90 mmHg or ii. Mean arterial pressure ≤ 65 mmHg or iii. Base deficit (BD) ≥5 meq or iv. Lactate ≥ 2 3. Or Injury Severity Score (ISS) greater than or equal to 15. 5. Ability to obtain Informed Consent prior to OR repair of injury. Exclusion Criteria will be: 1. Patients not expected to survive greater than 48 hours. 2. Prisoners. 3. Pregnancy. 4. Patients receiving chronic corticosteroids or immunosuppression therapies. 5. Previous bone marrow transplantation. 6. Patients with End Stage Renal Disease. 7. Patients with any pre-existing hematological disease. Elective Hip Repair Population Inclusion criteria will be: 1. All adults (age ≥18) 2. Patient undergoing elective hip repair for non-infectious reasons. 3. Ability to obtain Informed Consent prior to operation. Exclusion Criteria will be: 1. Pregnancy. 2. Prisoners. 3. Patients receiving chronic corticosteroids or immunosuppression therapies. 4. History of receiving Chemotherapy or Radiation within the last 6 months 5. Previous bone marrow transplantation 7\. Patients with End Stage Renal Disease 8. Patients with any pre-existing hematological disease
Where it's running
-
UF Health Shands Hospital at the University of Florida
Gainesville, Florida, United States Recruiting
Study contacts
- Principal investigator: Philip Efron, MD — University of Florida
- Study coordinator: Jennifer D Lanz, MSN
- Email: jennifer.lanz@surgery.ufl.edu
- Phone: 352-273-5497
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Geriatric Trauma Care Program for Older Adults Living Alone
This study tests a digital support program to help older adults with limb injuries who live alone see if it improves their recovery and daily living after injury.
-
Mortality in the ICU after trauma in Colombia
This study tests what factors are linked to death among trauma patients admitted to the ICU and compares them with other ICU admissions in Colombian hospitals.
-
Regional anesthesia techniques for pain control after pelvic and acetabular fracture surgery
This study will try regional anesthesia techniques to see if they lower pain and opioid use after pelvic or acetabular fracture surgery.
-
Using platelet-lymphocyte and platelet-neutrophil ratios to detect early trauma-related coagulopathy
This research will test if blood-count ratios (PLR and PNR) taken within six hours of injury can help detect early trauma-induced coagulopathy in patients who come to the emergency department.
-
Electrical bioimpedance imaging for high-energy limb fractures
This will test whether a portable electrical impedance tomography (EIT) device can image tissue changes in adults with high-energy closed limb fractures.
-
Therapy dog visits for hospitalized trauma patients
This project will test whether short visits from therapy dogs reduce pain and anxiety in adults hospitalized with traumatic injuries.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.